Abstract
Background: This two-center pilot study combined for the first time an intra-arterial glucose sensor with a decision support system for insulin dosing (SGCplus system) in critically ill patients with hyperglycemia. Methods: Twenty-two patients who were equipped with an arterial line and required iv insulin therapy were managed by the SGCplus system during their medical treatment at the intensive care unit. Results: Time to target was 111 ± 195 min (80-150 mg/dL) and 135 ± 267 min (100-160 mg/dL) in the lower and higher glucose target group. Mean blood glucose (BG) was 142 ± 32 mg/dL with seven BG values <70 mg/dL. Mean daily insulin dose was 62 ± 38 U and mean daily carbohydrate intake 148 ± 50 g/day (enteral nutrition) and 102 ± 58 g/day (parenteral nutrition). Acceptance of SGCplus suggestions was high (93%). Conclusions: The SGCplus system can be safely applied in critically ill patients with hyperglycemia and enables good glycemic control.
Originalsprache | Englisch |
---|---|
Seiten (von - bis) | 566-574 |
Seitenumfang | 8 |
Fachzeitschrift | Diabetes Technology and Therapeutics |
Jahrgang | 21 |
Ausgabenummer | 10 |
DOIs | |
Publikationsstatus | Veröffentlicht - Okt. 2019 |
ASJC Scopus Sachgebiete
- Medizinische Labortechnik
- Endokrinologie
- Endokrinologie, Diabetes und Stoffwechsel